Oishi Clinic

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Recruiting3 trials

Lead sponsor

• Pfizer2 trials
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

  NCT07794761· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

  NCT07794774· Phase 3· Pfizer· Source

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  NCT07282600· Phase 3· Eli Lilly and Company· Source

  Contact: Yayoi Oishi (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes1 recruiting